Adding an Artificial Tail—Anchor to a Peptide-Based HIV-1 Fusion Inhibitor for Improvement of Its Potency and Resistance Profile

por Su, Shan, Ma, Zhenxuan, Hua, Chen, Li, Weihua, Lu, Lu, Jiang, Shibo
Publicado 2017

Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in...

por Xie, Yiran, Zhu, Haoxiang, Guo, Yifei, Ma, Zhenxuan, Qi, Xun, Yang, Feifei, Mao, Richeng, Zhang, Jiming
Publicado 2022

Rational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations

por Zhu, Yun, Su, Shan, Qin, Lili, Wang, Qian, Shi, Lei, Ma, Zhenxuan, Tang, Jianchao, Jiang, Shibo, Lu, Lu, Ye, Sheng, Zhang, Rongguang
Publicado 2016

Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients

por He, Jingjing, Guo, Yifei, Zhang, Yao, Han, Jiajia, Chen, Jingwen, Jia, Yidi, Ma, Zhenxuan, Wu, Jingwen, Zhang, Shenyan, Li, Fahong, Mao, Richeng, Zhang, Jiming
Publicado 2023

Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection

por Yang, Feifei, Yu, Xueping, Zhou, Chenliang, Mao, Richeng, Zhu, Mengqi, Zhu, Haoxiang, Ma, Zhenxuan, Mitra, Bidisha, Zhao, Gan, Huang, Yuxian, Guo, Haitao, Wang, Bin, Zhang, Jiming
Publicado 2019